What is the difference between BOTOX® and BOTOX® Cosmetic?
BOTOX® (onabotulinumtoxinA) is approved for 20 different therapeutic indications in approximately 80 countries worldwide and has been approved in the U.S. for nearly 20 years to treat several medical conditions. The safety and efficacy of BOTOX® has been established in approximately 50 randomized, placebo-controlled clinical trials and in approximately 11,000 patients treated with BOTOX® and BOTOX® Cosmetic in Allergan’s clinical trials. Approximately 22 million vials of BOTOX® and BOTOX® Cosmetic have been distributed worldwide since the product was first approved. With approximately 2,000 articles on BOTOX® and BOTOX® Cosmetic in peer-reviewed publications, the product is one of the most widely researched medicines in the world. The same formulation with dosing specific to temporarily treat moderate to severe glabellar lines in people ages 18 to 65, was approved in 2002 as BOTOX® Cosmetic. Over the last seven years, BOTOX® Cosmetic has been the most popular physician-administered, ae
